Hypertrophic and Keloid Scar Treatment Market

Hypertrophic and Keloid Scar Treatment Market

A hypertrophic scar is a thickened, broad, and frequently elevated scar that develops as a result of an injury. This scar is typically the consequence of an aberrant reaction to damage or trauma. Keloids refer to reddish nodules that grow at the location of damage and have a raised look. Keloids can appear anywhere on the body, but they are most common in the upper back, shoulders, and upper chest. The increased awareness about aesthetic appearance is likely to result in the expansion of the global hypertrophic and keloid scar treatment market in the years to come. As a result, increased demand for different operations to improve aesthetic appeal is predicted to fuel market growth in the coming years.

Scar treatment helps in the improvement of aesthetic appeal by providing complete skin restoration. The demand for aesthetic products is mostly driven by women, who are the primary purchasers of these items. Besides, an increase in the frequency of burn cases and traffic accidents is likely to influence development of the global hypertrophic and keloid scar treatment market in the years to come. The need for topical solutions has increased with the rise in the number of cosmetic treatments across the globe. Treatment utilizing laser therapy, on the other hand, yields faster and more effective outcomes. Furthermore, they are the most popular treatment choice because they are not only painless but also less invasive.

Hypertrophic and Keloid Scar Treatment Market: Introduction

• A hypertrophic scar is a thickened, broad, and frequently raised scar that occurs because of an injury. A hypertrophic scar is typically the result of an abnormal reaction to trauma or damage. Keloids are reddish nodules that develop at the site of an injury and have a raised appearance. Keloids can appear anywhere on the body, but these are most common in the upper chest, shoulders, and upper back. Scars are a common complication of burn injuries; however, these can appear after piercings, wounds, or even acne. Hypertrophic scars are similar to keloid scars, but are less severe and do not spread beyond the original skin injury's boundaries.

Key Drivers, Restrains, and Opportunities of Global Hypertrophic and Keloid Scar Treatment Market

• Most of the patients who undergo scar treatment suffered injuries in a severe car accident. The number of road accidents has increased over the last decade. Moreover, burns and injuries caused during industrial work leave deep scars and marks. These factors boost the growth of the global hypertrophic and keloid scar treatment market.
• The portfolio of hypertrophic and keloid scar treatments has diversified in the past few times. This is attributed to the interest shown by medical investors in the global hypertrophic and keloid scar treatment market. Moreover, growth of the global hypertrophic and keloid scar treatment market is attributed to awareness initiatives about skin care and testing. Increase in dermatological research and testing is expected to augment the global hypertrophic and keloid scar treatment market. All age groups subscribe to skincare treatments, which is another key factor fueling the growth of the global hypertrophic and keloid scar treatment market.
• However, lack of universal treatment due to high cost, side effects, and lack of knowledge is likely to hamper the growth of the global market

North America to Capture Major Share of Global Hypertrophic and Keloid Scar Treatment Market

• North America is anticipated to account for major share of the global hypertrophic and keloid scar treatment market during the forecast period. High prevalence of burn injuries, skin-related ailments, and trauma propels the market in the region. Additionally, availability and uptake of advanced treatment alternatives, such as laser treatments, are expected to boost the growth of the market in the region.
• The hypertrophic and keloid scar treatment market in Asia Pacific is likely to grow at a rapid pace during the forecast period. This can be attributed to the availability of technologically advanced products as well as presence of a large number of manufacturers in countries such as China. Availability of low-cost laser devices in emerging markets has boosted their usage, which in turn is projected to fuel the growth of the market in the region.

Key Players Operating in Global Hypertrophic and Keloid Scar Treatment Market

The global hypertrophic and keloid scar treatment market is relatively consolidated, with the presence of small number of key players. These players hold major share in their respective regions.

Major players operating in the global hypertrophic and keloid scar treatment market are:

• Alliance Pharma plc
• Mölnlycke HEALTH CARE AB.
• Smith & Nephew
• Newmedical Technology, Inc.
• HRA Pharma
• Lumenis
• Other Prominent Players

Global Hypertrophic and Keloid Scar Treatment Market: Research Scope

Global Hypertrophic and Keloid Scar Treatment Market, by Scar Type

• Hypertrophic
• Keloid

Global Hypertrophic and Keloid Scar Treatment Market, by Product

• Topical Products
  • Silicone Sheets
  • Creams
  • Gels
  • Others
• Laser Products
  • Pulse-dyed
  • CO2
  • Others
• Injectable
• Others

Global Hypertrophic and Keloid Scar Treatment Market, by End-user

• Hospitals
• Clinics
• Retail Pharmacies/E-commerce

Global Hypertrophic and Keloid Scar Treatment Market, by Region

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Spain
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Australia & New Zealand
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa